Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | VANGL1 |
| Upstream (Parents) |
|---|
| (<<) CASP3 → VANGL1 |
| (<<) CDCP1 → VANGL1 |
| (<<) CDH3 → VANGL1 |
| (<<) CSNK1E → VANGL1 |
| (<<) CSTA → VANGL1 |
| (<<) CSTB → VANGL1 |
| (<<) E2F6 → VANGL1 |
| (<<) ELOVL1 → VANGL1 |
| (<<) HSPA8 → VANGL1 |
| (<<) KIAA0020 → VANGL1 |
| (<<) PLCG2 → VANGL1 |
| (<<) PPRC1 → VANGL1 |
| (<<) RASSF1 → VANGL1 |
| (<<) RORA → VANGL1 |
| (<<) RRP9 → VANGL1 |
| (<<) S100P → VANGL1 |
| (<<) SFN → VANGL1 |
| (<<) SH3GLB2 → VANGL1 |
| (<<) TAGLN2 → VANGL1 |
| (<<) TUBB2C → VANGL1 |
| (<<) VPS37B → VANGL1 |
| Downstream (Children) |
|---|
| VANGL1 → ADAM15 (>>) |
| VANGL1 → ARAF (>>) |
| VANGL1 → CDKN2A (>>) |
| VANGL1 → EPHA4 (>>) |
| VANGL1 → GNG12 (>>) |
| VANGL1 → KLK5 (>>) |
| VANGL1 → MPP1 (>>) |
| VANGL1 → MYO10 (>>) |
| VANGL1 → PIK3R3 (>>) |
| VANGL1 → POP1 (>>) |
| VANGL1 → PRKCG (>>) |
| VANGL1 → PTPLA (>>) |
| VANGL1 → RRP15 (>>) |
| VANGL1 → SERPINB2 (>>) |
| VANGL1 → TCEAL1 (>>) |
| VANGL1 → TRAF2 (>>) |
